These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 21819489
1. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Cocito D, Grimaldi S, Paolasso I, Falcone Y, Antonini G, Benedetti L, Briani C, Fazio R, Jann S, Matà S, Sabatelli M, Nobile-Orazio E, Italian Network for CIDP Register. Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489 [Abstract] [Full Text] [Related]
7. Immunotherapies in neurologic disorders. Graves D, Vernino S. Med Clin North Am; 2012 May 18; 96(3):497-523, x. PubMed ID: 22703853 [Abstract] [Full Text] [Related]
8. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients. Kim MR, Kim HC, Kim SC. Dermatology; 2011 May 18; 223(2):182-8. PubMed ID: 22025028 [Abstract] [Full Text] [Related]
10. Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases. Kim W, Shim YK, Choi SA, Kim SY, Kim H, Lim BC, Hwang H, Choi J, Kim KJ, Chae JH. Neuromuscul Disord; 2019 Sep 18; 29(9):684-692. PubMed ID: 31473049 [Abstract] [Full Text] [Related]
13. Rituximab in refractory chronic inflammatory demyelinating polyneuropathy. Muley SA, Jacobsen B, Parry G, Usman U, Ortega E, Walk D, Allen J, Pasnoor M, Varon M, Dimachkie MM. Muscle Nerve; 2020 May 18; 61(5):575-579. PubMed ID: 31922613 [Abstract] [Full Text] [Related]
14. Treating immunobullous diseases: an update. Reynaert S, Black MM. Dermatol Nurs; 2004 Feb 18; 16(1):29-34, 70. PubMed ID: 15022502 [Abstract] [Full Text] [Related]
15. Refractory bullous pemphigoid with fatal outcome in a young patient. Cruz MJ, Santos P, Morais P, Barreto F, Azevedo F. Int J Dermatol; 2013 May 18; 52(5):601-2. PubMed ID: 23590375 [No Abstract] [Full Text] [Related]
16. Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy. D'Amico A, Catteruccia M, De Benedetti F, Vivarelli M, Colucci M, Cascioli S, Bertini E. Eur J Paediatr Neurol; 2012 May 18; 16(3):301-3. PubMed ID: 21903431 [Abstract] [Full Text] [Related]
18. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study. Azar L, Springer J, Langford CA, Hoffman GS. Arthritis Rheumatol; 2014 Oct 18; 66(10):2862-70. PubMed ID: 24943239 [Abstract] [Full Text] [Related]
19. Sustained remission of CIDP associated with Evans syndrome. Knecht H, Baumberger M, Tobòn A, Steck A. Neurology; 2004 Aug 24; 63(4):730-2. PubMed ID: 15326255 [Abstract] [Full Text] [Related]